Pinned Tweet
Psilocybin-assisted therapy provides more than just relief from anxiety and depression in patients with cancer.
Our analysis in @NatMentHealth reveals improvements in obsession-compulsion, hostility, somatization, & more.
Read the full paper here: rdcu.be/dWeGR
Somatic symptom disorder has no FDA-approved medication, and cognitive behavioral therapy isn’t widely accessible. In a new case report in the @JCPjournal , I describe a medication that may be worth a closer look.
Two years later, she is still experiencing relief. Symptom severity (PHQ-15) fell from 19 to 8, symptom burden (SSS-8) from 15 to 13, and distress about her symptoms (SSD-12) from 47 to 28.
1
14
My hypothesis is that lamotrigine, by dampening glutamate, calms an overactive salience network, the brain circuit that decides which bodily signals deserve attention. One case is not proof, but it’s a target worth testing in controlled trials. bit.ly/4BZ81vp
7
Petros Petridis retweeted
Psilocybin treatment for opioid abuse disorder.
Dbl blind study at Hopkins.
Strong results.
So strong they can stop the study.
—R. I S. E. Summit Irvine CA
Petros Petridis retweeted
Psilocybin can work as a booster for the treatment of alcohol use disorder, not as a shortcut.
Our new paper in Drug and Alcohol Dependence reports the open-label extension of our phase 2 randomized trial of psilocybin-assisted therapy at NYU and the University of New Mexico.
Petros Petridis retweeted
The Siegel lab is still hiring - Post-doctoral fellowship neurojobs.sfn.org/job/40078/…
Come help us advance precision brain imaging 🧠 and psychopharmacology 🍄!
(please retweet and pass on to anyone that may be interested 🙏)
Psilocybin can work as a booster for the treatment of alcohol use disorder, not as a shortcut.
Our new paper in Drug and Alcohol Dependence reports the open-label extension of our phase 2 randomized trial of psilocybin-assisted therapy at NYU and the University of New Mexico.
What we found:
• Psilocybin was well tolerated, with no serious adverse events.
• All 9 people who were abstinent after the full psilocybin course stayed abstinent, and 4 more joined them.
• 5 of 8 who were abstinent after placebo resumed drinking, even after psilocybin.
1
6
These are exploratory, open-label findings, but they suggest psilocybin with therapy builds the foundation, and a booster adds to it but can’t replace it.
Free to read until Dec 12: authors.elsevier.com/c/1n~b2… 5/5
3
Petros Petridis retweeted
Elizabeth Richwine took psilocybin, the psychedelic compound in magic mushrooms, hoping it could relieve brain symptoms she had suffered from Lyme disease.
After the second session, she said, her symptoms disappeared for months. wapo.st/4xXO1qx
Hundreds of scans hint at how substances such as psilocybin, LSD and ayahuasca alter connections between key areas of the brain
go.nature.com/4tzwLVX
Petros Petridis retweeted
Psychedelics Can Dissolve Fear of Death. For Some People, They Are Transformative, Scientists Say popularmechanics.com/science…
Petros Petridis retweeted
I got to work with a psychedelic dream team on this! @RCarhartHarris, Conor Liston, Ginger Nicol, and Michael Bogenschutz
Very proud of what came out of it - - a rigorous, insightful, and authoritative review IMHO
New Review: The science of #psychedelic medicine.
Joshua Siegel & colleagues integrate mechanistic knowledge with clinical evidence across neuropsychiatric indications — highlighting challenges, controversies, and opportunities.
@realJoshSiegel @RCarhartHarris @nyugrossman
nature.com/articles/s41591-0…
Petros Petridis retweeted
Hiring: postdoc in my lab at @nyulangone (Center for Psychedelic Medicine) to lead precision neuroimaging + psychedelics translational research. Looking for strong neuroimaging + human subjects experience, a strong publication track record, and ability to communicate complex scientific ideas clearly (+ with beautiful, informative figures). Would start ~summer.
DM me + send CV + 2 papers.
Also looking for a neuroimaging engineer. Will post separately.
Petros Petridis retweeted
This 👇is the last revolution. We are working on the next one - and need your help.
HIRING: Postdoc at @nyulangone (Center for Psychedelic Medicine) to lead precision neuroimaging + psychedelics translational research. Looking for strong neuroimaging + human subjects experience, a strong publication track record, and ability to communicate complex scientific ideas clearly (+ with beautiful, informative figures). Would start ~summer.
DM me + send CV + 2 papers. Also looking for a neuroimaging engineer. Will post separately.
After a high dose of psilocybin, the brain desynchronizes at a massive scale, causing loss of our sense of self, time, and space. This may drive the burst of plasticity caused by psychedelics. The next day, brain activity has largely returned to normal, but an echo remains – a reset of circuits critical to the sense of self.
Our study is out today in @Nature nature.com/articles/s41586-0…
Petros Petridis retweeted
Johns Hopkins just dropped a free, 10-hour Coursera course unpacking the history, science, and clinical research behind psychedelic medicine. hopkinsmedicine.org/news/art…














